http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics
-
FDA approves Merck's subcutaneous KEYTRUDA QLEX across 38 cancer indications
-
FDA Approves Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA® (pembrolizumab)
-
Millennial Enters into Investor Relations Agreements to Raise Profile with Global Investment Community
-
CharCoin Launches on Solana: A Meme Coin Turning Every Transaction Into Global Good
-
Edimakor V4.3.0 Unveils AI Video and Enhanced Image Creation with Veo 3 & Nano Banana
-
Skywork.ai Redefines Enterprise Productivity with DeepResearch AI Agents Built for Real-World Industry Demands
-
Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories
-
Vishay to exhibit AI and EV components at PCIM Asia 2025
-
Vishay Intertechnology to Showcase Solutions for AI and EV Applications at PCIM Asia 2025
-
Bark and Shibo Recognized Among All-Time Leading Crypto Voices, as Doginal Dogs Gets the NFT Spotlight
-
DOJ CLOSES ITS "CASTE" INVESTIGATION INTO THE BAPS TEMPLE IN NEW JERSEY
-
Edimakor V4.3.0 Unveils AI Video and Enhanced Image Creation with Veo 3 and Nano Banana
-
Brennan, Manna & Diamond Successfully Launches TRĒ AI CRM/ERM in Same-Day Deployment
-
Spring Free EV Announces New Round of Financing Led by Spring Lane Capital
-
New Visual "Barbatos Rises at NYC" Unveiled as Gundam Takes Over the Big Apple
-
Lavras Gold Corp. to Present at the Toronto Mi3 Communications Event, Tuesday Sept 23, 2025
-
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2025
-
Le Walk, a tour guide in your headphones, raises $4.1M seed led by Adverb Ventures and Lerer Hippeau
-
Winter Landscapes Offer Chill Vibes
-
BexBack Launches Double Deposit Bonus and 100x Leverage Crypto Trading No KYC
-
XRP Tundra Presale at $0.01 with $2.50 Target Launch Price Draws Investor Interest
-
C2 Management Reinforces Investment Recovery Association Membership
-
Aprio Expands Midwest, Strengthens QSR Outsourcing with Mize CPAs Inc. and Prism Financial Group, L.L.C. Acquisition
-
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Tradewinds Universal and Peppermint Hippo Complete Interviews and Launch Official Investor Communications on X
-
Mega Matrix purchases $6 million in ENA tokens for stablecoin strategy
-
Mega Matrix Inc. Announces Accumulated $6 million ENA tokens Purchase, Reinforcing its Stablecoin Governance Tokens DAT Strategy
-
Green Rain Energy Holdings (OTC: $GREH) Announces Launch Of Its Quarterly Newsletter On Its Corporate Website
-
Forge Global Announces the 2025 Edition of the Private Magnificent 7, Now Representing Over a Trillion in Value
-
Immutable Seizes $121B Opportunity with Launch of Mobile Gaming Division
-
UPDF Web AI Deep Research Ushering in a New Era of Knowledge Discovery
-
CoinEx Charity Launches Global Blockchain-Powered Social Impact Campaign for 2025
-
CoinEx: 8 Years of Long-Termism in the Crypto Industry
-
TRYNGOLZA approved in Europe for rare genetic syndrome FCS
-
TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS)
-
CoinEx: User-Centric Approach to Building Trust and Value in the Crypto World
-
Merck receives positive EU opinion for RSV prevention drug ENFLONSIA
-
Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season
-
Merck receives positive EU opinions for KEYTRUDA subcutaneous form and head cancer use
-
Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer
-
ESET Research: Russian FSB-linked Gamaredon and Turla team up to target high-profile Ukrainian entities
-
HTX Opens Trading for BARD (Lombard)
-
Years of Security Commitment: CoinEx’s Ongoing Investment in Transparency and Safety
-
Wolters Kluwer completes capital reduction
-
AWAIM® Expands Global Investment Capabilities with SFC License for Hong Kong Operations
-
North Coast Brewing Company Wins Bronze for Laguna Baja at European Beer Star 2025
-
Greenberg Traurig Adds Technology-Focused Corporate Shareholder Daniel Wu in California
-
Pacific Ridge Announces Filing of NI 43-101 Technical Report for Kliyul Copper-Gold Project
-
Applications Now Open for HII’s 2026 Internship Program
